Project Grant R21DA060486
Award Date
4/15/25
Completion Date
3/31/27
Dollars Obligated
$268K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a randomized, controlled human laboratory study to investigate the effects of repeated cannabidiol (CBD) administration on the abuse-related and analgesic properties of smoked cannabis in healthy adult cannabis smokers. The $541,080 award will support this 5-year research project, which aims to assess whether daily oral CBD...
This $857,054 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a human laboratory study to investigate the combined therapeutic effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in individuals with co-occurring opioid use disorder (OUD) and chronic pain who are receiving opioid agonist therapy. The study aims to characterize the combined impact of THC and CBD on two key treatment...
The National Institute on Drug Abuse (NIDA) awarded a $188,482 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Colorado-Denver. The grant will fund a 5-year observational study to investigate the prevalence and maternal/child outcomes associated with cannabidiol (CBD)-only product use during pregnancy. Key objectives include: 1) Estimating the prevalence of CBD-only and cannabis use among pregnant women receiving prenatal care, 2)...
This $376,078 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the relationship between cannabis use for coping purposes and cannabis use quantity and frequency. The key objectives are to: 1) Experimentally test if cannabis use increases after stress induction among individuals who use cannabis for coping, 2) Examine if social anxiety and inhibitory control moderate the...
This R01 project grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to assess the neurobehavioral impacts of medical cannabis use in a sample of 120 patients in Minnesota, as compared to 60 non-cannabis using controls. The $663,150 award, with a project period from September 30, 2024, to May 31, 2029, will fund a comprehensive pre-post assessment of cognition, neural function, and substance use disorder risk in...
This $100,267 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research at the University of Mississippi to investigate the developmental impacts of cannabinoid exposure. The research aims to: Define the most sensitive developmental exposure windows, dose- and sex-dependence, and persistent molecular mechanisms of adverse effects from pre- and post-natal exposure to cannabinoids like THC and CBD....
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to West Virginia University to conduct a 5-year study on the effects of cannabidiol (CBD) on the driving performance and cognitive function of healthy adults aged 18-30. The study will use a randomized, double-blind, placebo-controlled design to determine the dose-dependent effects of CBD on driving ability, as well as associated...
This $350,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund a study on the developmental effects of environmental enrichment on minor cannabinoid drug reward and cannabinoid receptor levels. The key objectives are to: 1) investigate whether adolescent environmental enrichment can alter sensitivity to cannabis drugs like delta-8-THC and CBD, and 2) determine if enrichment exposure...
This $1,825,416 Project Grant awarded by the National Institute on Drug Abuse (NIDA) will fund research to develop and improve cannabis warning labels in the United States. The award supports the "Drug Use and Addiction Research Programs" federal grant program (CFDA 93.279). The primary goal is to examine the current landscape of cannabis warning regulations and experimentally determine the most effective warning characteristics for communicating the health risks of cannabis use. The...
The National Institute on Drug Abuse (NIDA) awarded a $424,545 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the RAND Corporation to conduct a national survey on naloxone use and access in the United States. The grant will fund two surveys over the project period from September 2024 to August 2026. One survey will collect data from a nationally-representative online sample, while the other will survey individuals self-reporting opioid dependence. The goal is to gather...